Previous Article | Next Article 
J Virol, June 1998, p. 4997-5005, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mapping of Homologous Interaction Sites in the
Hepatitis B Virus Core Protein
Sabine
König,1
Gertrud
Beterams,2 and
Michael
Nassal1,2,*
Zentrum für Molekulare Biologie,
University of Heidelberg, D-69120 Heidelberg,1
and
Department of Internal Medicine II, University
Hospital, University of Freiburg, D-79106
Freiburg,2 Germany
Received 15 December 1997/Accepted 17 February 1998
 |
ABSTRACT |
Hepatitis B virus consists of an outer envelope and an inner
capsid, or core, that wraps around the small genome plus the viral
replication enzyme. The icosahedrally symmetric nucleocapsid is
assembled from multiple dimeric subunits of a single 183-residue capsid protein, which must therefore contain interfaces for
monomer dimerization and for dimer multimerization. The atomic
structure of the protein is not known, but electron microscopy-based
image reconstructions suggested a hammerhead shape for the dimer and, very recently, led to a tentative model for the main chain trace. Here
we used a combination of interaction screening techniques and
functional analyses of core protein variants to define, at the primary
sequence level, the regions that mediate capsid assembly. Both the
two-hybrid system and the pepscan technique identified a strongly
interacting region I between amino acids (aa) 78 and 117 that probably
forms part of the dimer interface. Surprisingly, mutations in this
region, in the context of a C-terminally truncated but
assembly-competent core protein variant, had no detectable effect on
assembly. By contrast, mutations in a second region, bordered by aa 113 and 143, markedly influenced capsid stability, strongly suggesting that
this region II is the main contributor to dimer multimerization. Based
on the electron microscopic data, it must therefore be located at the
basal tips of the dimer, experimentally supporting the proposed main
chain trace.
 |
INTRODUCTION |
Hepatitis B virus (HBV), the
causative agent of acute and chronic B-type hepatitis in humans (for a
review, see reference 5), is a small enveloped DNA
virus that replicates via reverse transcription of an RNA intermediate
(for reviews, see references 24 and
25). Its 3.2-kb genome encodes a reverse
transcriptase (P), a transactivator (X), three envelope proteins, and a
single capsid, or core protein (C) of 183 amino acids (aa); a secreted, processed, and nonparticulate form of the protein is known as HBeAg.
Authentic nucleocapsids are generated, in a highly specific reaction,
by assembly of the capsid protein around a complex of P protein bound
to a structured RNA element on one of the viral transcripts; subsequent
conversion of the RNA into DNA yields mature core particles that
acquire their outer envelope during export from the cell (for a review,
see reference 26).
Heterologously expressed core protein, in the absence of further viral
products, still forms particles resembling authentic liver-derived HBV
capsids (10, 18). C-terminal truncations up to aa 144 or 140 rendered the protein assembly competent, while no particles were
detected with the further truncated and poorly expressed variants
ending with aa 138 or 139 (4, 43). These results defined the
first 140 aa as the assembly domain of the protein (Fig.
1). Functional studies in the context of
the complete viral genome demonstrated that the highly basic, R-rich C
terminus, starting at aa 150, acts as a nucleic acid binding domain
that is required for RNA encapsidation and proper reverse transcription (17, 22). Further genetic and biochemical analyses showed that the protein forms dimers that can be disulfide linked via the C-61
residues in the two monomers (23, 40) and that dimers are
the only detectable assembly intermediates (41). While
full-length capsids are extraordinarily stable, probably owing to the
additional interactions between the basic C terminus and
(nonspecifically) encapsidated RNA (4), capsids from
truncated variants can be dissociated into dimers that spontaneously
reassemble in vitro (39).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Structural organization of the HBV core protein. (A)
Functional domains. The bar represents the primary sequence. The
assembly domain is located in the first 144 aa and is followed by a
nucleic acid binding region containing four clusters of R residues
(indicated by +). The schematic representations of the core protein
dimer shown below are based on cryo-electron microscopic
reconstructions of capsids. The dimer interface forms the spikes
visible on the capsid surface, and the R-rich C termini face its
interior. (B) Architecture of the T=4 HBV capsid. A total of 120 dimers
are arranged on an icosahedrally symmetric surface lattice; two-,
three- and fivefold symmetry axes are indicated (adapted from reference
18). (C) Schematic representation of the arrangement of
dimers around a local sixfold (strict twofold) axis of symmetry. The
view is the same as in panel B.
|
|
After mapping studies of antibody-binding (27) and
protease-sensitive (reviewed in reference 26) sites,
more detailed structural information came from cryoelectron microscopic
analyses of capsids (12, 18, 43). They showed two classes of
icosahedrally symmetric particles, containing 90 (triangulation number
T=3) and 120 (T=4) hammerhead-shaped,
dyad-symmetry related dimers (Fig. 1A). Each dimer forms a prominent
spike on the particle surface (Fig. 1B). Very recent data at
resolutions below 10 Å revealed that the dimer interface is formed by
a four-helix bundle (6, 11), in accord with a theoretical
predicition (7). From these data, Böttcher et al.
(6) proposed a largely
-helical model for the fold of the
core protein, including a tentative main chain trace, that is
compatible with the available biochemical data.
In this study, we used a combination of interaction screening
techniques and functional analyses of mutant core proteins to identify,
at the primary sequence level, the regions in the protein that are
involved in mediating the contacts between subunits; the rationale was
that each monomer must have at least two interfaces, one mediating the
dimerization of monomers and the other mediating the multimerization of
dimers. The screening data revealed two prominent interaction regions,
one between aa 78 to 117 (region I) and the other between aa 113 to 143 (region II). To functionally test the relevance of these regions, a
series of core protein variants, designed according to the interaction
data, were expressed in Escherichia coli and assayed for
assembly competence. Surprisingly, mutations in region I had no
detectable effect, although from the electron microscopy-based model
(6), region I would overlap with two of the helices forming
the four-helix bundle in the dimer. By contrast, several mutations in
region II markedly affected particle stability, strongly suggesting
region II to be one of the elements, if not the major element, in
multimerization of the dimers. Since the dimer contacts are clearly
revealed at the fivefold and quasi-sixfold vertices in the electron
microscopy-based reconstructions, primary sequences between aa 113 and
143 are located at each of the two basal tips of the dimer.
 |
MATERIALS AND METHODS |
Plasmids.
Plasmids pGAD-HBc1/183 and pGBT-HBc1/183 contain a
synthetic full-length HBV C gene from plasmid pPLC4-1 (21)
cloned into the polylinker sequences of pGBT9 and pGAD424 (Clontech,
Heidelberg, Germany); these, as well as the corresponding HBV X gene
control constructs, were kindly provided by L. Runkel.
Plasmids encoding GAD fusions with C terminally truncated core protein
(pGAD/c1-36, pGAD/c1-47, pGAD/c1-81, pGAD/c1-94,
pGAD/c1-117, pGAD/c1-136, and pGAD/c1-149), or
internal fragments (pGAD/c28-47, pGAD/c36-149, pGAD/c42-117,
pGAD/c42-149, pGAD/c78-117, and pGAD/c94-117) were created by
excision of the corresponding C gene restriction fragments from
pPLC4-1, or existing pGAD derivatives, and insertion, after appropriate
modification of the ends, between the SmaI and BamHI sites in plasmid pGAD-3-stop; this pGAD424 derivative
carries a synthetic linker introducing stop codons in all three reading frames after the cloning sites between the original BamHI
and PstI sites
(GGATCCTAGGTGAGTGACCTGCAG;
stop codons underlined); hence, the fusion proteins carry only
two to four foreign amino acids at their C terminus. The plasmid names
indicate the first and last aa of the core protein present in the
encoded fusion proteins.
For the construction of the
E. coli expression plasmids, an
AlwNI site was first created at core nucleotide (nt) 294 by
silent
exchanges via PCR-mediated mutagenesis (CAA CTC
TTG

CA
G CTC
CTG; mutated residues in bold) of
plasmid pPLC/c1-149;
this derivative of plasmid pPLC4-1
(
21), under the control of
the phage lambda
pL promoter, produces substantial amounts of
particulate protein c1-149 upon heat induction (
4). Point
mutations
at aa T91 and K96 were introduced by replacing the
XbaI (nt 241)-
AlwNI
fragment with synthetic
oligonucleotide duplexes that were degenerate
at the respective codon
positions. Mutations at R127 and P138
were generated by replacing the
XbaI (nt 241)-
SalI (nt 420) fragment
with
PCR-derived fragments obtained with an appropriately degenerated
primer. Colonies were picked at random, and the individual sequences
were verified by sequencing. No attempts were made to isolate
all the
expected sequences. Plasmid pPLC/c1-124 was obtained,
within a series
of C-terminal truncations, by
Bal 31 nuclease
treatment of
HindIII-linearized plasmid pPLC/c1-149. All enzymes
for
molecular cloning experiments were either from Boehringer
(Mannheim,
Germany) or New England Biolabs (Bad Schwalbach, Germany)
and were used
as specified by the manufacturer.
Bacterial and yeast strains.
For plasmid preparations,
E. coli Top10 (Invitrogen, NV Leek, The Netherlands) was
used. Expression experiments were performed either by thermoinduction
(42°C) of appropriately transformed E. coli NF1
(29) cells (this strain carries an integrated copy of the
temperature-sensitive lambda cI857 repressor) or by
tryptophan induction of the corresponding GI724 or GI698 (Invitrogen)
cells (in these strains, synthesis of the lambda cI
repressor is suppressed by the addition of tryptophan); transformation
and protein induction were performed as specified by the manufacturer
recommendations; usually, the cells were grown to an optical density of
0.5 (600 nm) and induced for 3 to 4 h at 32°C; the P138G variant
could be expressed in soluble form only at 23°C.
For the two-hybrid experiments, yeast strains HF7c and SFY526
(Clontech) grown in YPD medium (
2) were used. Yeast
transformations
were performed by the lithium acetate method
essentially as described
previously (
2), except that the
transformed HF7c cells were
grown for 2 days in plasmid-selecting
liquid medium before an
aliquot was plated on His

plates.

-Galactosidase (

-gal) activity was assayed in SFY526
cells grown
in His-containing medium or in HF7c cells grown without
His, after
replica plating the yeast colonies on filters containing
X-Gal
(5-bromo-4-chloro-3-indolyl-

-
D-galactoside). Double
transformants
containing pGAD/c1-183 and pGBT/c1-183 were positive in
all assays.
Negative controls included either plasmid alone, a
combination
of pGAD/c1-183 and pGBT/HBx, and the reverse combination;
all
were negative in the growth test and in the

-gal assay. For all
constructs scoring positive in the SFY526 cell

-gal assays,
specificity
was confirmed by demonstrating that no reaction occurred
with
pGBT/HBx.
Protein purification.
Protein c1-149 capsids were purified
as previously described (4). Briefly, bacterial cells from 1 liter of induced culture were lysed by sonication and core protein was
precipitated with 40% saturated ammonium sulfate. The precipitate was
resuspended in phosphate-buffered saline (PBS) (140 mM NaCl, 2 mM
NaH2PO4, 8 mM Na2HPO4
[pH 7.4]) and subjected to sedimentation in 10 to 60% (wt/vol)
sucrose gradients in PBS (SW-40 rotor; 30,000 rpm for 15 h at
4°C). Fourteen 0.9-ml fractions were collected, and the presence of
core protein was assayed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (0.1% SDS, 15% polyacrylamide) in the
Laemmli system (19) with Coomassie blue staining. The same procedure was used for variants mutated at aa T91, K96, and P138.
For variants R127L and R127Q, no particles were observed on analytical
sucrose gradients after the ammonium sulfate precipitation
step. The
precipitate was dissolved in 9 ml of 25 mM sodium phosphate
(pH 8.0)
and dialyzed overnight at 4°C against the same buffer
containing 2 M
urea. Aliquots of 5 ml were subjected to size exclusion
chromatography
with a fast protein liquid chromatography system
(Pharmacia, Freiburg,
Germany) on a Hiload 16/60 Superdex 200HR
column equilibrated in the
same buffer. Both proteins eluted at
a volume expected for dimers and
were used without further purification.
Protein c1-124 was similarly
enriched by size exclusion chromatography
on Superdex 75HR.
Small-scale sucrose gradients.
Cells from 30-ml cultures
were collected by low-speed centrifugation, and the pellets were
sonicated in 0.3 ml of PBS. The lysates were cleared by centrifugation,
and 0.2 ml of the soluble fraction was loaded onto 10 to 60% (wt/wt)
sucrose gradients (six steps of 0.2 ml each) in PBS (TLS55 rotor;
55,000 rpm for 40 min at 20°C), essentially as previously described
(42). Fourteen fractions of 0.1 ml were collected from the
top, and 10 to 20 µl of each fraction was monitored for core proteins
by SDS-PAGE as described above or by Western blotting. Dimeric core
protein, together with the bulk of E. coli proteins, was
typically present in fractions 1 to 3, and capsids were present in
fractions 6 to 8. For protein P138G, the sedimentation analysis was
repeated on gradients containing TAE buffer (40 mM Tris-acetic acid
[pH 8.1], 0.1 mM EDTA). The same gradient system was also used for analytical purposes.
Agarose gel electrophoresis of core particles.
Agarose gel
assays were performed as previously described (4). In brief,
fractions containing between 1 and 10 µg of purified or enriched core
protein were loaded on 1% (wt/vol) agarose (SeaKem; FMC Bioproducts,
Natick, Maine) gels in TAE buffer and electrophoresed for about 3 h at 10 V/cm. In some experiments, encapsidated RNA was visualized by
staining with 0.5 µg of ethidium bromide per ml and illumination at
302 nm. Proteins were stained with Coomassie blue. Core
protein-specific bands were detected, after blotting the contents of
the gel by capillary transfer in 20× SSC (0.3 M sodium citrate [pH
7.0], 3 M NaCl) to a nylon membrane (Porablot NY; Macherey-Nagel,
Düren, Germany), with the monoclonal antibodies mc275 and mc312
(31, 32). Differential capsid stabilities were assayed by
including 1 M urea in the gel.
Pepscan analysis.
The pepscan filters (Jerini Bio Tools,
Berlin, Germany) contained all possible 15-mer peptides spanning the
core protein sequence from positions 1 to 161, each shifted by 2 positions. Pretreatment of the filter, incubation with core protein,
and detection were performed essentially as recommended by the
supplier. In brief, after blocking with 5% nonfat milk powder in
Tris-buffered saline (TBS) (100 mM Tris-HCl [pH 8.0], 150 mM NaCl)
containing 5% sucrose, the filter was incubated at 4°C overnight
with the respective core protein (about 30 µg in 10 ml of the same
buffer without milk powder). After two washes with TBS, four sequential
electrophoretic transfers of the protein to a polyvinylidene difluoride
(PVDF) membrane (Millipore, Eschborn, Germany) were performed. Core
protein on the membranes was detected immunologically with the enhanced chemiluminescence system (Amersham, Braunschweig, Germany).
Dissociation and reassociation of capsids.
Dissociation of
gradient-purified capsids was performed by overnight dialysis against
25 mM sodium phosphate (pH 8.0) containing 2 M urea. Dimer formation
was monitored by using analytical sucrose gradients and size exclusion
chromatography in PBS as described above. For reassociation, isolated
dimers, stored in phosphate buffer containing 2 M urea, were dialyzed
overnight at 37°C against 25 mM sodium phosphate (pH 7.0) containing
100 or 500 mM NaCl.
Immunological techniques.
For Western blotting experiments,
the core proteins present on polyacrylamide or agarose gels were
transferred to PVDF or nylon membranes and analyzed with monoclonal
antibodies mc312, recognizing aa 76 to 84 as a linear epitope (31,
32), and mc275, recognizing only particulate core protein
(32). Both antibodies were kindly provided as horseradish
peroxidase conjugates by Behringwerke (Marburg, Germany). Detection was
performed with the enhanced chemiluminescence substrate.
 |
RESULTS |
A two-hybrid-system screen suggests the presence of a central
(region I) and an N-proximal (region III) interaction site in the HBV
core protein.
The yeast two-hybrid system (14, 20, 38)
is an increasingly popular tool for identifying protein-protein
interactions. Here we used a fusion of the complete HBV core gene with
the Gal4 DNA binding domain (encoded by plasmid pGBT/c1-183) to screen a series of constructs encoding N-terminal and internal fragments of
the core gene fused to the Gal4 activation domain (pGAD derivatives) (Fig. 2). An interaction between the
fusion proteins should allow yeast cells containing both plasmids to
grow on His
medium and to produce
-gal, giving rise to
blue colonies on X-Gal-containing medium. As a positive control, a
combination of plasmids pGBT/c1-183 and pGAD/c1-183, both containing
the complete core gene, was used and produced the expected phenotypes.
Individually or in combination with the respective HBV X gene plasmids,
both constructs were negative in both assays, confirming the
specificity of the test system. Of the constructs encoding C-terminally
truncated core protein fusions, all except c1-81 scored positive in
the
-gal and His
growth test in Hf7 cells (Fig. 2),
although differences in plating efficiency that probably relate to the
strength of the interactions were seen (16). The smallest
fragment contains residues 1 to 36, suggesting the presence of an
interaction site(s) in the N-terminal region (region III). In SFY526
cells, this construct did not give rise to blue colonies on X-Gal
plates. By contrast, plasmid pGAD/c1-117, like pGAD/c1-183 and
pGAD/c1-149, was clearly also positive in the SFY526 strain,
suggesting the presence of one or more additional stronger interaction
sites.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Homologous interactions detected with the yeast
two-hybrid system. (Left) Overview of the pGAD/core fusion constructs.
The bars below the schematic representation of the core protein
indicate the core protein fragments present in individual constructs
with respect to the primary sequence (central line). The short thick
lines at the ends symbolize the presence of two to four vector-derived
amino acids. Shaded areas correspond to the detected interaction
regions I and III. (Right) Interaction data obtained with double
transformants containing pGBT/c1-183 and the corresponding pGAD
construct. The numbers indicate the first and last core-specific amino
acids present in each construct. All constructs were tested for growth
on His medium and for -gal activity in HF7c cells;
selected constructs were also tested for -Gal activity in SFY526
cells. nd, not determined.
|
|
This was confirmed by using the series of constructs encoding internal
core protein fragments. Those containing aa 42 to 149,
42 to 117, 78 to
117, and 94 to 117 conferred growth on His

medium and
gave blue colonies in HF7 cells. pGAD/c78-117 was
also positive in the

-gal assay in strain SFY526, indicating
that this sequence contains
a prominent interaction site, which
we will refer to as region I; in
the electron microscopy-based
structure model (
6), this
region would be part of the sequence
forming the dimer interface.
Plasmid pGAD/c28-47 scored negative in all assays, suggesting that
this sequence does not contribute to interactions. Surprisingly,
construct pGAD/c36-149, but not pGAD/c42-149, was also negative,
although it contains region I; a similar effect was seen with
pGAD/c1-81, which also contains the sequence 1 to 36, which by
itself was positive in Hf7 cells. Possibly, the additional sequences
present in the two proteins lead to misfolding and/or instability.
Together, these experiments identified the core sequence 78 to 117, i.e., region I, as a major interaction site. The positive
growth test
with pGAD/c1-36, in view of the clearly negative results
with some
other constructs, suggests the presence of an additional,
N-proximal
interaction site, i.e., region III. To independently
confirm these
conclusions and to distinguish between regions involved
in dimerization
and multimerization, which is intrinsically difficult
with the
two-hybrid system, as well as for a more precise mapping,
we turned to
the pepscan technique.
The pepscan technique confirms region I as a strong interaction
site and suggests the presence of an additional C-proximal interacting
region (region II).
In the pepscan technique, originally developed
by Geysen et al. (15), the sequence of a protein is
represented as a series of relatively short overlapping peptides that
are immobilized on a solid support, e.g., cellulose filters (for a
review, see reference 28). The filter is then probed
with the protein of interest. Detection of the protein on the filter,
directly or after transfer to a second membrane, identifies interacting
peptides.
Here we used filters containing the core protein sequence 1 to 161 as
15-mer peptides, each shifted by 2 aa, and incubated
them with dimers
of core protein c1-149 obtained by dissociation
of purified capsids.
Since the dimer interface should not be accessible
in this probe, we
expected it to identify mainly peptides involved
in dimer
multimerization. After incubation, the protein was electrophoretically
transferred from the filter to PVDF membranes; usually four sequential
transfers were performed to optimize the signal-to-background
ratio.
Protein c1-149 was then detected with a polyclonal rabbit
anti-core
antiserum and an anti-rabbit immunoglobulin G-peroxidase
conjugate with
a chemiluminescent substrate.
A typical result is shown in Fig.
3A. In
addition to a few individual weakly reactive spots, e.g., peptides 15 to 29, 17 to
31, and 25 to 39 and several C-terminal peptides (starting
with
137 to 151), two major extended regions comprising adjacent
peptides
were identified. Region I starts with peptides 83 to 97 and
ends
with peptides 101 to 115. In several experiments, the first 5
of
the 10 peptides reacted more strongly than the following ones;
region I
was therefore subdivided into regions Ia and Ib (Fig.
3C). The second
series of spots started with peptides 113 to 127
and extended to
peptides 129 to 143. As outlined below, this region
(region II) also
appeared to bipartite and hence was divided into
subregions IIa and
IIb. Together, these data suggested that the
sequences from 83 to 115 and 113 to 143 contain important interaction
sites. In particular,
region I identified by the pepscan technique
is almost exactly
congruent with the sequence comprising region
I in the two-hybrid
screen (aa 78 to 117). In view of the electron
microscopy-based model,
however, the reactivity of region I in
the pepscan assay was
surprising, since it should be part of the
dimer interface that would
not be expected to be available for
further interactions with the
dimeric protein probe.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Pepscan analysis of homologous interactions. (A) Dimeric
protein c1-149 as a probe. The core protein sequence from aa 1 to 161 was represented on the filter by 15-mer peptides, each shifted by two
positions. The sequences of the first and last peptide in each row are
given on the left and the right, respectively. Protein bound to
individual spots on the filter was electrophoretically transferred to a
PVDF membrane and detected immunologically. Three N-proximal peptides
that might correspond to region III in the two-hybrid screen are marked
by asterisks. The strongly interacting regions I and II, with
subregions a and b, are boxed. (B) Core protein c1-124 as a probe. The
pepscan filter was treated as in panel A, except that the
assembly-deficient variant c1-124 was used as the probe. (C)
Correlation of regions I and II with the primary sequence of the core
protein. The indicated borders of complete regions I and II and their
subregions a and b correspond to the first amino acid of the first and
the last amino acid of the last interacting peptide. Residues that are
common to all peptides of a subregion are shaded in the primary
sequence.
|
|
Together, the pepscan data confirmed a strong interaction in region I,
as in the two-hybrid assay, and suggested a second
important site
within the C-proximal region II; whether the signals
with three
peptides between aa 15 and 39 correspond to the N-proximal
region III
in the two-hybrid screen is unclear, since they were
rather weak and
were not contiguous as in regions I and II. Possibly,
the putative site
encoded by pGAD/c1-36 is discontinuous and may
not be properly
represented by the 15-mer peptides on the filter.
Because of the
uncertainties inherent in both interaction screening
techniques, we
next sought to more directly test the relevance
of regions I and II in
capsid assembly.
Analysis of the assembly competence of core protein variants
mutated in regions I and II.
If the above-defined candidate
regions were indeed important for assembly, changes in their primary
sequences would be expected to influence capsid formation and/or
stability. We therefore expressed, in E. coli, several core
protein variants mutated in the respective regions and characterized
their quaternary structure by sedimentation in sucrose gradients, by
electrophoresis on native agarose gels, and by gel filtration.
As a first step, we analyzed the effect of deleting most of the
C-proximal region II; this was not possible for region I because
of its
internal localization. Previous experiments had shown that
variants
truncated after aa 138 and 139 did not form particles
(
4).
However, the corresponding proteins were very poorly expressed.
Since
capsid assembly is a concentration-dependent process (
33,
34), the low concentration of these variants might have
substantially
contributed to the lack of detectable particle formation.
Within
a series of further truncation constructs (to be described
elsewhere),
we found that a variant ending with aa 124 (c1-124) was
well expressed
in soluble form. When analyzed on sucrose gradients,
most of the
protein sedimented with the bulk of soluble proteins in
fractions
1 to 3, while c1-149, known to form capsids, was present
mostly
in fractions 6 to 8 (Fig.
4A).
Hence, even at concentrations allowing
efficient particle formation
with c1-149, c1-124 is assembly deficient,
suggesting a critical role
for the amino acid sequence between
residues 125 and 149 in capsid
assembly. Next, we used gel filtration
on Superdex 75HR to determine
whether c1-124 still formed dimers
under native conditions. As shown
in Fig.
4B, c1-124, with a calculated
molecular mass of about 14 kDa,
eluted from the column slightly
after the 29-kDa marker but clearly
ahead of the 12.4-kDa marker;
c1-149, as expected, was present in the
void volume. With a different
set of markers (data not shown), the
protein eluted between ovalbumin
(44 kDa) and myoglobin (17 kDa),
confirming its dimeric nature.
This demonstrates that the residues
forming the dimer interface
are still present in c1-124. When c1-124
was used as a probe in
the pepscan analysis (Fig.
3B), the most
prominent signals were
again detected in region I; in region II,
however, only the more
N-proximal peptides covering the sequence from
113 to 133, i.e.,
region IIa, were reactive while the peptides
comprising the residues
121 to 143, i.e., region IIb, gave no signals.
Hence, the region
IIb signals observed with c1-149 but not c1-124 are
most probably
due to homologous interactions between these C-proximal
residues,
and these are important for the multimerization of dimers.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Quaternary structure of core protein c1-124. (A)
Sedimentation analysis. E. coli-derived protein c1-124
(upper panel) was sedimented on an analytical sucrose gradient.
Aliquots from each fraction were analyzed by SDS-PAGE and staining with
Coomassie blue. Essentially all of the protein was present in the four
top fractions (arrow), cosedimenting with the lysozyme (L) used during
preparation of the cell lysate. The molecular masses of the marker
proteins (lane M) are indicated on the right. Protein c1-149 was
analyzed in parallel (lower panel) and was present mainly in fractions
6 to 8. (B) Size exclusion chromatography. Bacterial lysates containing
protein c1-124 or c1-149 were analyzed on a Superdex 75 column
equilibrated in PBS. The elution profiles and the positions of the two
proteins as determined by SDS-PAGE are indicated. The dashed line shows
the elution profile for a set of protein markers with the indicated
molecular masses. AU280 nm, absorbance units at 280 nm.
|
|
Next we introduced, in the context of protein c1-149, several point
mutations into regions I and II (Fig.
5).
Based on a mutational
pepscan analysis (data not shown) in which the
central peptides
86 to 100 and 127 to 139 were resynthesized on the
filter with
each position being substituted individually with a series
of
other amino acids (V, I, A, D, F, G, L, P, Q, S, W, or Y), T91
and
K96 in region I and R127 and P138 in region II were chosen
as targets.
At these positions, one or more substitutions reduced
the signal
intensities when the filter was probed with c1-149.
P138, in addition,
is one of several clustered P residues in the
sequence from 129 to 144 (Fig.
5) and is highly conserved in the
core proteins of mammalian HBV.
It was also of interest because
its replacement by G apparently
prevented the production of particulate
core protein from a recombinant
vaccinia virus (
8).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Point mutations in regions I and II. In the context of
core protein c1-149, T91 and K96 in region I and R127 and P138 in
region II were replaced by the indicated amino acids. P138 is located
in a P-rich motif; P residues are underlined.
|
|
All region I variants tested (T91 replaced by L, M, R, or S; K96
replaced by A, H, N, T, or Y) sedimented essentially like
particulate
c1-149 (data not shown), indicating that their assembly
capability was
not significantly affected by the mutations. Particle
formation by the
variants was confirmed by electrophoresis in
native agarose gels
(
35,
36). In this assay (
4), capsids,
but not
soluble proteins with their higher diffusion coefficients,
migrate as
distinct sharp-edged bands. The capsid specificity
of the assay was
further enhanced by blotting the proteins onto
a membrane followed by
immunological detection with the particle-specific
monoclonal antibody
mc275, which is essentially nonreactive with
nonassembled core protein
(
32). A representative assay is shown
in Fig.
6. All of the T91 and K96 mutants, after
staining with
Coomassie blue, produced bands with a shape
characteristic for
capsids; this interpretation was confirmed by an
immunoblot with
mc275. Interestingly, all K96 variants (substituting
the basic
lysine side chain with neutral residues) migrated slightly
faster
than c1-149 capsids, while substitutions of the neutral T91
residue
by the positively charged arginine, but not with neutral
residues,
dramatically retarded migration toward the anode. Since
electrophoretic
mobility in the gel is a function of size and surface
charge (
35,
36), these data suggest that the corresponding
residues contribute
to the surface charge of the particle. Reasoning
that the mutations
might affect particle stability rather than
principal assembly
proficiency, we repeated the agarose gel assay in
the presence
of 1 M urea (Fig.
6, right panels). However, all the
variant capsids
remained stable. Hence, we were unable to demonstrate,
under these
conditions, any phenotypic consequences of the mutations in
region
I. Essentially the same result was obtained with three different
double mutants (T91L K96N, T91R K96N, and T91R K96Y [data not
shown]).

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 6.
Agarose gel electrophoresis assay of region I and II
mutants. Capsid fractions from small-scale sucrose gradients of the
indicated core proteins, all in the context of c1-149, were subjected
to electrophoresis in agarose gels, in either the absence (left) or the
presence (right) of 1 M urea. The amino acids present at positions 91, 96, and 127 in the wild-type protein and the individual variants are
indicated at the top. The upper panels show Coomassie blue-stained
gels; the lower panels show immunoblots with monoclonal antibodies
mc275 and mc312. Only the sharp-edged bands visible in the Coomassie
blue stain correspond to particles. Note that variant R127L formed
particles only in the absence of urea (arrow), while no particles at
all could be detected for variant R127Q.
|
|
By contrast, the region II mutations R127L and R127Q clearly affected
assembly. Sedimentation analysis of the crude
E. coli lysates showed that R127L was present in the same fractions (mainly
fractions 6 to 9) as particulate c1-149; the bulk of R127Q sedimented
slowly, with at most one-third being present in capsid-specific
fractions (Fig.
7A). Attempts to purify
the variants as capsids
by our standard method involving an ammonium
sulfate precipitation
as an early step were unsuccessful; no particles
could be detected
by sedimentation after this procedure. Instead, the
two variant
proteins were enriched in dimeric form by size exclusion
chromatography
in the presence of 2 M urea. We then tried to reassemble
them,
in vitro, into particles (see Materials and Methods for details).
Under conditions leading to essentially complete reassociation
of
dimeric c1-149, only a small amount of R127L and almost nothing
of
R127Q was present in particle-specific gradient fractions (Fig.
7B).
The low stability of the mutant capsids was confirmed in
the agarose
gel assay (Fig.
6, lanes R127 L and Q). Variant R127L,
in the absence
of urea, showed a typical capsid band that was
also detected by mc275.
No reaction was seen with the more diffusely
distributed
slower-migrating material visible in the Coomassie
blue stain. With 1 M
urea in the gel, however, the capsid-specific
band disappeared and no
signal was obtained with mc275. The presence
of the protein was
confirmed by immunological detection with another
monoclonal antibody,
mc312, which recognizes a linear epitope
between aa 76 and 84. Variant
R127Q did not produce a particle-specific
band even in the absence of
urea (lanes 127Q). Hence, mutations
of R127, in the center of region II
defined by the pepscan technique,
significantly reduce particle
stability, confirming a critical
role for region II residues in
multimerization.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 7.
Sedimentation analysis of R127 variants. (A) Analytical
sucrose gradients of crude E. coli lysates. Aliquots of
crude lysates from bacteria transformed with the appropriate expression
plasmids encoding proteins c1-149 and its R127 variants were subjected
to sedimentation in 10 to 60% sucrose gradients without prior ammonium
sulfate precipitation. Aliquots of each fraction were analyzed by
SDS-PAGE and Coomassie blue staining. R127L sedimented essentially to
the same central fractions as did wild-type protein c1-149, while most
of protein R127Q was present in the top fractions. (B) Reassociation of
isolated dimers. Variants R127L and R127Q, purified as dimers by size
exclusion chromatography, were subjected to reassociation conditions,
in parallel with isolated c1-149 dimers (see Materials and Methods for
details), and the reaction products were analyzed on analytical sucrose
gradients. These conditions led to efficient reassociation of the
wild-type protein (top), while only small amounts of the variant
proteins were detected in particle-specific fractions.
|
|
Finally, we subjected variant P138G to similar tests. When expressed at
42°C from a thermoinducible vector system (
21),
essentially all of the protein was present in the insoluble
fraction,
suggesting nonspecific aggregation; the R127 variants,
by contrast,
were mostly soluble under these conditions.
Expression at 23°C,
however, with a system in which induction is
chemically induced
by the addition of tryptophan, yielded mainly
soluble P138G in
particulate form, as shown by sedimentation analysis
(Fig.
8A).
Suspecting that the variant
capsids might be thermolabile, we
incubated an aliquot of the
preparation side by side with c1-149
capsids at 42°C overnight and
reanalyzed it on a sucrose gradient
run in PBS. Most of the
contaminating
E. coli proteins aggregated
under these
conditions to fast-sedimenting material (fraction
11); however, the
variant protein was still present in the same
capsid-specific fractions
as c1-149. Interestingly, however, P138G
capsids were not
detectable in the agarose gel mobility assay,
even in the absence of
urea (Fig.
8B). This apparent discrepancy
is probably related to the
higher pH (8.1) and lower ionic strength
(40 mM Tris-acetic acid)
of the TAE buffer used in our standard
agarose gel assay than those
used in the sedimentation analysis
(pH 7.4, PBS); both parameters
discourage the assembly of c1-149
particles (
39). Indeed,
when the sucrose gradients were run
in TAE buffer, P138G was completely
present in the nonparticulate
fraction.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 8.
Particle formation by variant P138G. (A) Sedimentation
analysis. E. coli-derived variant P138G particles were
sedimented, in parallel with protein c1-149, on 10 to 60% sucrose
gradients after overnight incubation at room temperature (left) or at
42°C (right). Proteins in individual fractions were detected by
SDS-PAGE and Coomassie blue staining. The molecular masses of the
marker proteins (lanes M) are indicated in the middle; L, lysozyme.
Note that both core proteins are present mainly in the central
fractions while most of the contaminating E. coli proteins
formed fast-sedimenting material (fraction 11) at 42°C. (B) Agarose
gel assay. Purified particles from protein c1-149 and its variant
P138G, as well as the assembly-deficient variant c1-124, were
subjected to electrophoresis in agarose gels containing no urea or 1 M
urea (see the legend to Fig. 6). The proteins were stained with
Coomassie blue. While c1-149 particles remained stable at 1 M urea
(white arrows), no particle-specific bands could be detected for the
variants.
|
|
Together, the characterization of the above-described core protein
derivatives clearly revealed a major contribution to the
assembly of
residues located in region II, while mutations in
region I had
surprisingly little effect.
 |
DISCUSSION |
Until recently, direct structural information about the HBV core
protein remained scarce and theoretical predictions yielded controversial results (1, 7). Here we used a combination of
screening procedures to experimentally define primary sequences within
the protein that are involved in mediating the contacts between the 240 or 180 subunits forming the complete shell of the HBV capsid. Below we
discuss the results in the context of the structural model proposed for
the core protein by very recent high-resolution electron
microscopy-based reconstructions (6, 11). Our data provide
experimental evidence that the electron density visible at the fivefold
and local sixfold symmetry axes between the core protein dimers in the
capsid is provided mainly by residues from the sequence 113 to 143, i.e., region II, in accord with proposed model. The data for residues
83 to 115, i.e., region I from the two-hybrid and the pepscan
screening, however, are not immediately understood in terms of the
model.
Comparison of the two-hybrid system and the pepscan results.
Since the HBV capsid is assembled from multiple core protein dimers,
one subunit must have at least one interface mediating the dimerization
of monomers and one mediating the multimerization of dimers. Both the
two-hybrid system (14, 20, 38) and the pepscan technique
(28) appeared able to define specific sequences involved in
these interactions. In the two-hybrid screen, the interaction between
full-length core protein fused to the GAD and GBT domains was clearly
detectable in both the His
growth assay and the
-Gal
assay. Within a series of terminal deletion constructs (Fig. 2),
c78-117 was the smallest core protein fragment that gave the same
phenotype, suggesting the presence of a strong interaction site in
this region (region I). These results are compatible with the
electron microscopy-based (6) as well as the theoretical
(7) structural models, since region I overlaps largely with
residues predicted to be part of the central helices at the dimer
interface. Evidence for an additional interaction site (region III)
within the first 36 aa was provided by fragment c1-36, which scored
positive in both tests in HF7c cells but displayed a decreased plating
efficiency on His
medium and no detectable
-Gal
activity in the SFY526 strain, suggesting a weaker interaction
(13, 14). That N-terminal residues are important for capsid
formation is supported by the known detrimental effect of even short
N-terminal deletions or insertions on assembly (3, 37).
The predominant pepscan signals obtained with dimeric c1-149 as the
probe spanned aa 83 to 115 (region I) and aa 113 to 143
(region II).
The striking agreement with region I defined by the
two-hybrid screen
suggested that both data sets reflect the same
strong interaction. In
view of the structural model, however,
these pepscan data created a
paradox because the dimer interface
should not be accessible on the
dimeric c1-149 protein probe.
One speculative explanation is that the
filter-bound peptides,
owing to their high local concentration (about 1 nmol per spot
of about 5 mm
2), are able to penetrate the
dimer interface by substituting for
authentic interactions within
the four-helix bundle. Further experiments
are required to substantiate
the implied partial or complete dissociation,
or at least structural
alteration, of the dimer interface and
to clarify the exact nature of
these interactions; however, the
data provided a guideline for the
introduction of site-directed
mutations into the core protein that
allowed us to directly analyze
their effects on particle formation.
Functional analysis of the relevance of regions I and II in HBV
capsid assembly.
As surprising as the reactivity of region I
peptides with dimeric c1-149 protein was the lack of a detectable
assembly defect of region I variants at T91 and/or K96 when analyzed in
the context of c1-149. The proteins formed particles in E. coli, and these capsids were stable in the agarose gel assay even
in the presence of 1 M urea. Unless one doubts the electron
microscopy-based assignment of the corresponding residues to the dimer
interface (6) this suggests that the mutations were not
radical enough to significantly perturb the monomer-monomer
interaction. In keeping with such a very robust nature of the dimer
interface, which is also predicted by the four-helix-bundle model, is
our observation that mutants with C61 replaced by W or R form stable
particles (data not shown) although C61 is clearly located in the dimer
interface, since it readily forms a homologous disulfide bridge with
the same residue in a second subunit (23, 40). While these
questions will probably be resolved only by direct higher-resolution
structural analyses, a coherent picture for the role of region II
emerged from our data.
First, variant c1-124, lacking most of region II, still formed dimers
but was assembly deficient even at concentrations of
about 0.1 mM,
i.e., 10- to 100-fold higher than the critical concentration
for
assembly estimated from expression of full-length and C-terminally
truncated core protein in
Xenopus laevis oocytes (around 1 and
10 µM [
34]). Hence, the lack of assembly
competence correlated
directly with the absence of aa 125 to 149. The
data also confirmed
that the dimer interface is located within the
first 124 aa of
the protein (Fig.
9A),
pointing in turn to an important role for
region II in dimer
multimerization. In view of the earlier deletion
analyses and the
selective of loss of pepscan signals in region
IIb (peptides 121 to 135 to peptides 129 to 143) with c1-124 as
a probe, it is highly likely
that majority of the region II residues
is involved in this process.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 9.
Location of regions I and II in the core protein dimer.
(A) Top and side view of the dimer. Region II is represented as a
dark-shaded area at each of the two basal tips of the dimer. Region I
most probably corresponds to residues forming the dimer interface. (B)
Arrangement of dimers around a local sixfold axis. According to the
mapping of region II (A), the contacts between individual dimers rely
mainly on residues located between positions 113 and 143, forming a
network around the local sixfold axes. Only one of the two contact
sites in each dimer is shown. (C) Arrangement of dimers around a
fivefold axis. Based on its icosahedral symmetry, the T=4 capsid must
contain 12 pentameric arrangements of dimers. The contacts mediated by
region II are similar to those at the local sixfold axes but not
identical, implying a certain structural flexibility.
|
|
The results obtained with the variants at R127 and P138 further
substantiate an important role for region II in dimer multimerization.
On sucrose gradients, only a fraction of variant R127Q was present
in
particulate form in crude
E. coli lysates; purified R127Q
dimers
could not be reassembled under conditions allowing the efficient
reassociation of c1-149 dimers, and no particles could be detected
by
the agarose gel assay. A similar though less pronounced phenotype
was
observed for variant R127L, which formed particles that were
detectable
in the agarose gel assay but disintegrated in the presence
of 1 M urea.
P138G particles were stable on sucrose gradients
run in PBS, even after
prolonged incubation at 42°C, but could
not be detected in the
agarose gel assay. Reanalysis by sedimentation
in TAE-buffered sucrose
revealed that, in contrast to c1-149,
all the variant protein was
present in the nonparticulate fraction,
indicating that P138G capsids
are unstable under these conditions.
Since both deletion of region II (c1-124) and mutation of residues in
its central (R127) or C-terminal (P138) part profoundly
affected
multimerization but did not abolish dimerization, we
conclude that
region II, encompassing the sequence from 113 to
143, contains at least
one element if not the major element, driving
the assembly of HBV core
protein dimers (Fig.
9A) by forming a
framework of homologous
interactions between region II residues
from multiple dimers. Hence,
our data provide experimental evidence
that the electron density seen
in the electron microscopy-based
image reconstructions around the
fivefold and twofold axes of
symmetry is contributed mainly by region
II residues (Fig.
9B),
corroborating the assignment in the model by
Böttcher et al.
(
6). They are also in accord with the
recent localization of
residue 150, by electron microscopic
visualization of a covalently
attached undecagold cluster
(
44), underneath the outer tips
of the dimer; this residue
is only a few positions away from the
C-terminal border of our region
II.
Based on this assignment, the assembly deficiency of c1-124 is
self-evident. The more subtle effects of the point mutations,
e.g., at
R127 and P138, suggest that these changes introduce perturbations
in
the network of interacting C-proximal residues that, depending
on the
specific substitution, have gradually different effects
on capsid
formation and stability. That they are tolerated at
all probably
reflects a certain flexibility in the structure of
region II, which is
naturally required to accommodate the quasi-equivalent
but nonidentical
contacts where five (at the fivefold axes) and
six (at the strict
twofold axes) subunits meet (Fig.
9B and C).
Since these contacts are
nonetheless similar, they will respond
similarly to dissociating
conditions, explaining why dimers rather
than higher-order multimers
such as pentamers (as seen, for instance,
with poliovirus VP1-VP3-VP0
protomers [
30]), are the only stable
intermediates in
HBV capsid assembly (
41). The distinct role
of region II in
assembly also sheds light on the formation of
mixed capsids
(
9) from core protein dimers of HBV and of woodchuck
hepatitis B virus (WHV): overall, the WHV core protein sequence
from 1 to 143 is 66% identical to that of HBV, while in region
II (aa 117 to
143) the proteins exhibit 85% identity.
In summary, the approach of using interaction screens with protein
segments and peptides, combined with functional analyses
of variant
proteins to map individual contact sites on the HBV
core protein, has
yielded valuable information, in particular
on the importance of the
C-proximal region II in multimerization.
However, the shortcomings
of the individual methods revealed in
this study also strongly
suggest a cautious interpretation of
data that are derived by a
single-interaction technique.
 |
ACKNOWLEDGMENTS |
We thank Andrea Frank for excellent technical assistance and
Heinz Schaller for valuable discussions.
This work was supported by grants from the Bundesministerium für
Bildung und Forschung and from the "protein-protein interactions" program of the Land of Baden-Württemberg.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Internal Medicine II, University Hospital, University of Freiburg,
Hugstetterstr. 55, D-79106 Freiburg, Germany. Phone and fax: 49 - 761 - 270 - 3507. E-mail: nassal2{at}ukl.uni-freiburg.de.
 |
REFERENCES |
| 1.
|
Argos, P., and S. D. Fuller.
1988.
A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins.
EMBO J.
7:819-824[Medline].
|
| 2.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
I. G. Seidman,
J. A. Smith, and K. Struhl.
1996.
In
Current protocols in molecular biology, vol. 2.
John Wiley & Sons, Inc., New York, N.Y.
|
| 3.
|
Beames, B., and R. E. Lanford.
1995.
Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation.
J. Virol.
69:6833-6838[Abstract].
|
| 4.
|
Birnbaum, F., and M. Nassal.
1990.
Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.
J. Virol.
64:3319-3330[Abstract/Free Full Text].
|
| 5.
|
Blumberg, B. S.
1997.
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.
Proc. Natl. Acad. Sci. USA
94:7121-7125[Free Full Text].
|
| 6.
|
Böttcher, B.,
S. A. Wynne, and R. A. Crowther.
1997.
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy.
Nature
386:88-91[Medline].
|
| 7.
|
Bringas, R.
1997.
Folding and assembly of hepatitis B virus core protein: a new model proposal.
J. Struct. Biol.
118:189-196[Medline].
|
| 8.
| Bringas, R. Personal communication.
|
| 9.
|
Chang, C.,
S. Zhou,
D. Ganem, and D. N. Standring.
1994.
Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential.
J. Virol.
68:5225-5231[Abstract/Free Full Text].
|
| 10.
|
Cohen, B. J., and J. E. Richmond.
1982.
Electron microscopy of hepatitis B core antigen synthesized in E. coli.
Nature
296:677-678[Medline].
|
| 11.
|
Conway, J. F.,
N. Cheng,
A. Zlotnick,
P. T. Wingfield,
S. J. Stahl, and A. C. Steven.
1997.
Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy.
Nature
386:91-94[Medline].
|
| 12.
|
Crowther, R. A.,
N. A. Kiselev,
B. Böttcher,
J. A. Berriman,
G. P. Borisova,
V. Ose, and P. Pumpens.
1994.
Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy.
Cell
77:943-950[Medline].
|
| 13.
|
Estojak, J.,
R. Brent, and E. A. Golemis.
1995.
Correlation of two-hybrid affinity data with in vitro measurements.
Mol. Cell. Biol.
15:5820-5829[Abstract].
|
| 14.
|
Fields, S., and R. Sternglanz.
1994.
The two-hybrid system: an assay for protein-protein interactions.
Trends Genet.
10:286-292[Medline].
|
| 15.
|
Geysen, H. M.,
S. J. Rodda,
T. J. Mason,
G. Tribbick, and P. G. Schoofs.
1987.
Strategies for epitope analysis using peptide synthesis.
J. Immunol. Methods
102:259-274[Medline].
|
| 16.
|
Golemis, E. A.,
J. Gyuris, and R. Brent.
1994.
Interaction trap/two-hybrid system to identify interacting proteins, p. 13.14.1-13.14.17.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, I. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
|
| 17.
|
Hatton, T.,
S. Zhou, and D. N. Standring.
1992.
RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication.
J. Virol.
66:5232-5241[Abstract/Free Full Text].
|
| 18.
|
Kenney, J. M.,
C.-H. von Bonsdorff,
M. Nassal, and S. D. Fuller.
1995.
Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores.
Structure
3:1009-1019[Medline].
|
| 19.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 20.
|
McNabb, D. S., and L. Guarente.
1996.
Genetic and biochemical probes for protein-protein interactions.
Curr. Opin. Biotechnol.
7:554-559[Medline].
|
| 21.
|
Nassal, M.
1988.
Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization.
Gene
66:279-294[Medline].
|
| 22.
|
Nassal, M.
1992.
The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly.
J. Virol.
66:4107-4116[Abstract/Free Full Text].
|
| 23.
|
Nassal, M.,
A. Rieger, and O. Steinau.
1992.
Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking.
J. Mol. Biol.
225:1013-1025[Medline].
|
| 24.
|
Nassal, M., and H. Schaller.
1993.
Hepatitis B virus replication.
Trends Microbiol.
1:221-226[Medline].
|
| 25.
|
Nassal, M., and H. Schaller.
1996.
Hepatitis B virus replication an update.
J. Viral Hepatitis
3:217-226[Medline].
|
| 26.
|
Nassal, M.
1996.
Hepatitis B virus morphogenesis.
Curr. Top. Microbiol. Immunol.
214:297-337[Medline].
|
| 27.
|
Pushko, P.,
M. Sällberg,
G. Borisova,
U. Rudén,
V. Bichko,
B. Wahren,
P. Pumpens, and L. Magnius.
1994.
Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.
Virology
202:912-920[Medline].
|
| 28.
|
Reineke, U.,
R. Sabat,
A. Kramer,
R. D. Stigler,
M. Seifert,
T. Michel,
H. Volk, and J. Schneider-Mergener.
1996.
Mapping protein-protein contact sites using cellulose-bound peptide scans.
Mol. Diversity
1:141-148.
[Medline] |
| 29.
|
Remaut, E.,
H. Tsao, and W. Fiers.
1981.
Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda.
Gene
15:81-93[Medline].
|
| 30.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
|
| 31.
|
Salfeld, J.,
E. Pfaff,
M. Noah, and H. Schaller.
1989.
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus.
J. Virol.
63:798-808[Abstract/Free Full Text].
|
| 32.
|
Sällberg, M.,
U. Ruden,
L. O. Magnius,
H. P. Harthus,
M. Noah, and B. Wahren.
1991.
Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.
J. Med. Virol.
33:248-252[Medline].
|
| 33.
|
Seifer, M.,
S. Zhou, and D. N. Standring.
1993.
A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes.
J. Virol.
67:249-257[Abstract/Free Full Text].
|
| 34.
|
Seifer, M., and D. N. Standring.
1995.
Assembly and antigenicity of hepatitis B virus core particles.
Intervirology
38:47-62[Medline].
|
| 35.
|
Serwer, P.
1986.
Use of gel electrophoresis to characterize multimolecular aggregates.
Methods Enzymol.
130:116-132[Medline].
|
| 36.
|
Serwer, P.,
S. A. Khan, and G. A. Griess.
1995.
Non-denaturing gel electrophoresis of biological nanoparticles: viruses.
J. Chromatogr. A
698:251-261[Medline].
|
| 37.
|
Ulrich, R.,
M. Nassal,
H. Meisel, and D. H. Krüger.
1998.
Core particles of hepatitis B virus as carrier for foreign epitopes.
Adv. Virus Res.
50:141-182[Medline].
|
| 38.
|
Warbrick, E.
1997.
Two's company, three's a crowd: the yeast two hybrid system for mapping molecular interactions.
Structure
5:13-17[Medline].
|
| 39.
|
Wingfield, P. T.,
S. J. Stahl,
R. W. Williams, and A. C. Steven.
1995.
Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.
Biochemistry
34:4919-4932[Medline].
|
| 40.
|
Zheng, J.,
F. Schödel, and D. L. Peterson.
1992.
The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern.
J. Biol. Chem.
267:9422-9429[Abstract/Free Full Text].
|
| 41.
|
Zhou, S., and D. N. Standring.
1992.
Hepatitis B virus capsid particles are assembled from core-protein dimer precursors.
Proc. Natl. Acad. Sci. USA
89:10046-10050[Abstract/Free Full Text].
|
| 42.
|
Zhou, S.,
S. Q. Yang, and D. N. Standring.
1992.
Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes.
J. Virol.
66:3086-3092[Abstract/Free Full Text].
|
| 43.
|
Zlotnick, A.,
N. Cheng,
J. F. Conway,
F. P. Booy,
A. C. Steven,
S. J. Stahl, and P. T. Wingfield.
1996.
Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein.
Biochemistry
35:7412-7421[Medline].
|
| 44.
|
Zlotnick, A.,
N. Cheng,
S. J. Stahl,
J. F. Conway,
A. C. Steven, and P. T. Wingfield.
1997.
Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA.
Proc. Natl. Acad. Sci. USA
94:9556-9561[Abstract/Free Full Text].
|
J Virol, June 1998, p. 4997-5005, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Newman, M., Chua, P. K., Tang, F.-M., Su, P.-Y., Shih, C.
(2009). Testing an Electrostatic Interaction Hypothesis of Hepatitis B Virus Capsid Stability by Using an In Vitro Capsid Disassembly/Reassembly System. J. Virol.
83: 10616-10626
[Abstract]
[Full Text]
-
Walker, A., Skamel, C., Vorreiter, J., Nassal, M.
(2008). Internal Core Protein Cleavage Leaves the Hepatitis B Virus Capsid Intact and Enhances Its Capacity for Surface Display of Heterologous Whole Chain Proteins. J. Biol. Chem.
283: 33508-33515
[Abstract]
[Full Text]
-
Nassal, M., Leifer, I., Wingert, I., Dallmeier, K., Prinz, S., Vorreiter, J.
(2007). A Structural Model for Duck Hepatitis B Virus Core Protein Derived by Extensive Mutagenesis. J. Virol.
81: 13218-13229
[Abstract]
[Full Text]
-
Vorreiter, J., Leifer, I., Rosler, C., Jackevica, L., Pumpens, P., Nassal, M.
(2007). Monoclonal Antibodies Providing Topological Information on the Duck Hepatitis B Virus Core Protein and Avihepadnaviral Nucleocapsid Structure. J. Virol.
81: 13230-13234
[Abstract]
[Full Text]
-
Cooper, A., Shaul, Y.
(2006). Clathrin-mediated Endocytosis and Lysosomal Cleavage of Hepatitis B Virus Capsid-like Core Particles. J. Biol. Chem.
281: 16563-16569
[Abstract]
[Full Text]
-
Kaukinen, P., Vaheri, A., Plyusnin, A.
(2003). Mapping of the Regions Involved in Homotypic Interactions of Tula Hantavirus N Protein. J. Virol.
77: 10910-10916
[Abstract]
[Full Text]
-
Wootton, S. K., Yoo, D.
(2003). Homo-Oligomerization of the Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein and the Role of Disulfide Linkages. J. Virol.
77: 4546-4557
[Abstract]
[Full Text]
-
Kreft, S. G., Nassal, M.
(2003). hRUL138, a novel human RNA-binding RING-H2 ubiquitin-protein ligase. J. Cell Sci.
116: 605-616
[Abstract]
[Full Text]
-
Riedl, P., Stober, D., Oehninger, C., Melber, K., Reimann, J., Schirmbeck, R.
(2002). Priming Th1 Immunity to Viral Core Particles Is Facilitated by Trace Amounts of RNA Bound to Its Arginine-Rich Domain. J. Immunol.
168: 4951-4959
[Abstract]
[Full Text]
-
Beck, J., Vogel, M., Nassal, M.
(2002). dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases. Nucleic Acids Res
30: 1679-1687
[Abstract]
[Full Text]
-
Seeger, C., Mason, W. S.
(2000). Hepatitis B Virus Biology. Microbiol. Mol. Biol. Rev.
64: 51-68
[Abstract]
[Full Text]
-
Hui, E. K.-W., Yi, Y. S., Lo, S. J.
(1999). Hepatitis B viral core proteins with an N-terminal extension can assemble into core-like particles but cannot be enveloped. J. Gen. Virol.
80: 2647-2659
[Abstract]
[Full Text]
-
Tellinghuisen, T. L., Hamburger, A. E., Fisher, B. R., Ostendorp, R., Kuhn, R. J.
(1999). In Vitro Assembly of Alphavirus Cores by Using Nucleocapsid Protein Expressed in Escherichia coli. J. Virol.
73: 5309-5319
[Abstract]
[Full Text]
-
Kratz, P. A., Bottcher, B., Nassal, M.
(1999). Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. USA
96: 1915-1920
[Abstract]
[Full Text]
-
Koschel, M., Thomssen, R., Bruss, V.
(1999). Extensive Mutagenesis of the Hepatitis B Virus Core Gene and Mapping of Mutations That Allow Capsid Formation. J. Virol.
73: 2153-2160
[Abstract]
[Full Text]